National
BREAKING: Obama endorses SNDA, SSIA anti-bullying bills
Support comes as White House hosts screening of movie “Bully”
President Barack Obama (Blade file photo by Michael Key)
President Obama has thrown the full weight of his administration behind a pair of bills that would help protect LGBT students against bullying: the Student Non-Discrimination Act and the Safe Schools Improvement Act.
Shin Inouye, a White House spokesperson, confirmed for the Washington Blade on Friday that Obama supports both pieces legislation — bringing him into alignment with a position that many LGBT organizations had sought for some time.
“The president and his administration have taken many steps to address the issue of bullying,” Inouye said. “He is proud to support the Student Non-Discrimination Act, introduced by Senator Franken and Congressman Polis, and the Safe Schools Improvement Act, introduced by Senator Casey and Congresswoman Linda Sanchez. These bills will help ensure that all students are safe and healthy and can learn in environments free from discrimination, bullying and harassment.”
Both pieces of legislation address bullying in different ways. SNDA would prohibit and harassment in public elementary and secondary schools based on a student’s actual or perceived LGBT status. SSIA would require schools to adopt anti-bullying codes of conduct and submit to states data to the Department of Education on bullying.
Education Secretary Arne Duncan echoed the sentiments expressed by the White House on the legislation in a statement delivered later in the day.
“Bullying can no longer be seen as a normal rite of passage,” Duncan said. “As a country, we must all work together to take action against bullying and improve the safety climates of our schools and communities. That’s why I support the Student Non-Discrimination Act and the Safe Schools Improvement Act. I would like to thank Sen. Al Franken, Sen. Bob Casey, Rep. Jared Polis and Rep. Linda Sanchez for introducing these bills and for their commitment to putting an end to bullying, discrimination and harassment in our nation’s schools. I also want to thank Rep. Danny Davis for his leadership on this issue to help keep every student safe and learning.”
Obama endorses the legislation as his administration has taken flak from the LGBT community for saying it won’t issue at this time an executive order requiring federal contractors to have non-discrimination policies based on sexual orientation and gender identity.
On the same day the endorsement was announced, the White House was set to host a screening of “Bully,” a 2011 documentary about school bullying that follows the lives of five students who were bullied on a daily basis.
The screening takes place on the “National Day of Silence” on which students take a day-long vow of silence representative of the silencing of LGBT students and their supporters.
On the movie, Inouye said, “Today, the White House Office of Public Engagement is holding a screening of the documentary ‘Bully’ at the White House with bullying prevention advocates from a wide range of communities.”
LGBT groups commended the Obama for expressing explicit support for legislation aimed to help students who face bullying.
Eliza Byard, executive director of the Gay & Lesbian Straight Education Network, called the announcement “a vital show of support” to students across the country “of all identities, backgrounds and beliefs who face bullying and harassment in school.”
“By speaking out on GLSEN’s Day of Silence in support of these two critical bills, the president has given greater hope to students who often feel that they have nowhere to turn,” Byard said. “It is deeply moving to know that lesbian, gay, bisexual and transgender students who face the multiple threats of harassment, violence and discrimination have the president as an ally in their efforts to win all of the protections that they deserve.”
Ian Thompson, the ACLU’s legislative representative, said White House support for SNDA is s “key to getting this necessary legislation passed into law.”
“Our public schools should be a safe harbor for our youth, not a place of exclusion and ridicule,” Thompson said. “By passing the Student Non-Discrimination Act, Congress can have a profound and very real impact in improving the lives of LGBT students. It’s time to make passage of this bill a priority.”
Hayley Gorenberg, deputy legal director of Lambda Legal, said the president’s support represents “a big step toward a safer and healthier environment in every public school.”
“At Lambda Legal, we’ve encountered extraordinary cases of violence and discrimination against LGBT young people in schools – and sometimes against the allies who try to support them,” Gorenberg said. “Gay, lesbian, bisexual and transgender students have long been at a significant disadvantage without specific protection under federal law. All students have a right to a safe learning environment, and this law will leave no doubt as to public schools’ responsibility to provide it.”
The endorsement comes as possible Senate votes on the anti-bullying bills could take place later this year. Education reform legislation known as Elementary & Secondary Education Act reauthorization was reported out of committee without the LGBT-specific anti-bullying provisions. Sens. Al Franken (D-Minn.) and Bob Casey (D-Pa.) have pledged to bring up their bills as amendments when the larger education reform bill reaches the floor.
Praise for Obama came from Franken, who said support from the president would help advance SNDA.
“There’s a lot of talk right now about the need for a law to protect our children from anti-gay bullying and discrimination,” Franken said. “My Student Non-Discrimination Act would protect LGBT children from bullying in the same way that children are already protected from bullying because of their race, gender, disability, and religion. With today’s endorsement from the White House and 37 cosponsors in the Senate, we’re that much closer to getting a law in place that will protect our children.”
Polis, who’s gay, expressed similar gratitude for the president’s support for the House version of the legislation, saying the bill “will help ensure that LBGT students can attend school free of harassment, discrimination and violence.”
“This endorsement is an enormous step forward for equality, but on a human level it is about the right of any student in America to attend school and learn without the fear of being bullied,” Polis said. “I intend to work with President Obama and Senator Franken, who introduced the companion bill, to see that the Student Non-Discrimination Act becomes the law of the land.”
Groups had been calling on Obama to endorse anti-bullying legislation. In a letter dated March 7, a group of 70 organizations — including the Human Rights Campaign, the ACLU, Lambda Legal and the Gay, Lesbian & Straight Education Network — to place the full support of his administration behind SNDA
Administration officials, such as Thomas Perez, assistant attorney general for the Justice Department’s Civil Rights Division, have previously said the administration supports “the goals” of SNDA, but have stopped short of endorsing the bill.
Earlier in the day, Duncan ducked a question on whether the Obama administration was prepared to endorse SNDA.
Under questioning from the Washington Blade during a White House news conference, Duncan declined to say whether the administration was ready to endorse SNDA, but touted the administration’s work on the issue and called for solidarity in confronting student harassment.
“We have to continue to do everything we can to make sure that there is zero tolerance for this,” Duncan said. “I met with one of the young women in the movie this morning with her father. It was very personal for me and for the president because we all have children going to school now.”
Duncan said an “unprecedented level” of work has taken place under the Obama administration on bullying, citing the first-ever White House summit against bullying in March 2011 and what he said was the passage of state anti-bullying laws throughout the country.
“I’ll tell you, some of my toughest meetings have been with parents who have lost their children or committed suicide due to the impact,” Duncan said. “So, we all have to continue to work together.”
Pressed to clarify on whether the Obama administration was prepared to endorse legislation, Duncan didn’t answer and took a question from another reporter.
A transcript of the exchange between Duncan and the Blade follows:
Washington Blade: Mr. Secretary, this afternoon, the White House is going to be screening a viewing of the movie “Bully.” One piece of legislation that would protect LGBT students against bullying is called the Student Non-Discrimination Act, which would prohibit harassment and discrimination against LGBT students in school. Is the administration prepared to endorse that legislation at this time?
Arne Duncan: Well, we have to continue to do everything we can to make sure that there is zero tolerance for this. I met with one of the young women in the movie this morning with her father. It was very personal for me and for the president because we all have children going to school now.
When we have children going to school scared, it’s hard to concentrate on biology and algebra. So, as a country, we have already seen an unprecedented level of support from our administration: the first-ever anti-bullying summit here in the White House. The president talked about his own experiences there.
We’ve seen many states toughen laws to try and protect students from bullying. Until our children are safe and secure at recess, in the morning, after school. It’s not just physical bullying; it’s cyber-bullying, as you know.
I’ll tell you, some of my toughest meetings have been with parents who have lost their children or committed suicide due to the impact. So, we all have to continue to work together.
I think this movie is very hard hitting. It tells the truth. We hope it’ll create a greater awareness around the country. This cannot be a normal rite of passage. We can’t accept it.
Blade: What about the legislation? Are you endorsing the legislation?
NOTE: This post has been updated.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Your guide to D.C.’s queer New Year’s Eve parties
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Using movement to boost your mental health during holidays
Reasons to be optimistic about 2026
America is going in the wrong direction for intersex children
Rush reopens after renewing suspended liquor license
Long-awaited ‘Pillion’ surpasses the sexy buzz
